April 22, 2024

BIO International Convention

BIO International Convention

From 16.06.2025 – 19.06.2025 the BIO International Convention, the largest and most comprehensive event for biotechnology will take place in Boston, US. With 20 000 industry leaders from across the globe the BIO is representing the full ecosystem of biotech.

Join the German Pavilion, where innovative companies are eager to connect and share their groundbreaking solutions! Organized with the support of BMWK, the German Pavilion provides outstanding opportunity for companies to showcase their expertise. There are two options available:

  • A: Companies which may participate at reduced rates:

1) Information Center (IZ) (small stand package approx. 2 m²) EUR 1,450.00

2) Stand from 6 m² EUR 575,- per m² (stand size up to 100 m²)

Exhibitor Booth Partnering: first access EUR 400,-

  • B: Companies that are not allowed to participate at discounted conditions (public companies or similar)

1) IZ (small stand package approx. 2 m²) EUR 4.200,-

2) Stand from 6 m² EUR 1.650,- per m² (stand size up to 100 m²)

Since the beginning of 2024, registration is only possible digitally. (i.e. analogous to this year’s BIO) Please follow this link: First you have to register for the portal. You can then complete your registration. Please note the registration deadline of December 9, 2024.

Act fast – limited slots available! Slots for German companies are limited, so seize the opportunity now. After registering in the trade fair portal of the Federal Ministry here https://registration.german-pavilion.com, you will find the registration documents there: https://registration.german-pavilion.com/exhibitor/participation/fair/1026

Application deadline: 9th December 2024. Don’t miss the chance to be part of this groundbreaking event where we will foster together the visibility of our vibrant Life Science ecosystem!

register now

Our latest News

discover more
RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers

RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers

Heidelberg, Germany, 19.12.2024 – RHEACELL today received approval from the European Medicines Agency (EMA) for its blinded, multi-centric Phase-3 trial (NCT06489028) evaluating allo-APZ2-CVU in patients with chronic venous ulcers (CVU). The pivotal trial will be conducted at more than 100 sites and is expected to enroll 250 patients, starting enrollment in Europe in Q1 2025. […]

Common cough syrup ingredient shows promise in treating serious lung disease

Common cough syrup ingredient shows promise in treating serious lung disease

EMBL scientists discover that an FDA-approved, over-the-counter cough syrup ingredient has potential to treat fibrotic lung disease. Summary A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions.  Scientists from EMBL Heidelberg were part of a […]

Antibody that Neutralizes Inhibitory Factors Involved in Nerve Regeneration Leads to Enhanced Motor Function after Acute Spinal Cord Injury

Antibody that Neutralizes Inhibitory Factors Involved in Nerve Regeneration Leads to Enhanced Motor Function after Acute Spinal Cord Injury

Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers at 13 clinics in Germany, Switzerland, the Czech Republic and Spain have investigated this with promising results. For the first time, it was possible to identify patient groups that displayed a clinically relevant treatment effect. A follow-up study will start in December […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp